Detalhe da pesquisa
1.
Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis.
Clin Transl Gastroenterol
; 11(8): e00218, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32955190
2.
Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
Inflamm Bowel Dis
; 25(11): 1862-1870, 2019 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-31006801